Anders Karlborg sold $7.5M of VRT
EVP, Man., Logistics and Op Ex at Vertiv Holdings Co. 30,487 shares at an average of $246.92, traded Feb 26, 2026, filed Mar 2, 2026.
Score components
- +15RoleOfficer
- +25Trade size$7.5M at market
- +10Share of holdings soldSold 47% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +0.7%, 3m +25.5%, 6m +0.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950142-26-000579, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | MOption exercise Class A Common Stock | +4,783 | $14.49 | $69k | 39,529 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Class A Common Stock | +9,823 | $11.25 | $111k | 49,352 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Class A Common Stock | +6,080 | $15.84 | $96k | 55,432 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Class A Common Stock | +4,047 | $24.87 | $101k | 59,479 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Class A Common Stock | +5,754 | $72.09 | $415k | 65,233 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stock | -10,290 | $245.17 | $2.5M | 54,943 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stock | -7,500 | $246.54 | $1.8M | 47,443 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stock | -3,350 | $247.66 | $830k | 44,083 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Class A Common Stock | -9,347 | $248.89 | $2.3M | 34,746 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Optionderivative | -4,783 | - | - | 4,784 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Optionderivative | -9,823 | - | - | 9,823 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Optionderivative | -6,080 | - | - | 12,160 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Optionderivative | -4,047 | - | - | 8,096 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Optionderivative | -5,754 | - | - | 17,263 | Mar 2, 2026 |
Related signals
Other insiders at Vertiv Holdings Co and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Vertiv Holdings Co | Edward L Monser director | $3.9M 15,287 shares | -48% | |
| 40Moderate | Vertiv Holdings Co | Edward L Monser director | $19M 77,294 shares | -82% | |
| 80Strong | Vertiv Holdings Co | David M Cote Executive Chairman | $10M 40,000 shares | -64% | |
| 60Notable | Vertiv Holdings Co | Jan Van Dokkum director | $9.8M 38,647 shares | -61% | |
| 75Notable | Vertiv Holdings Co | Roger Fradin director | $51M 203,333 shares | -186% | |
| 75Notable | Vertiv Holdings Co | Steven Reinemund director | $25M 100,000 shares | -75% | |
| 59Moderate | VRTsell Vertiv Holdings Co | Stephen Liang Chief Technology Officer & EVP | $938k 5,501 shares | -58% | |
| 60Notable | Vertiv Holdings Co | Jakki L. Haussler director | $1.9M 15,680 shares | -328% | |
| 65Notable | Vertiv Holdings Co | Steven Reinemund director | $13M 100,000 shares | -43% | |
| 60Notable | Vertiv Holdings Co | Paul Ryan Chief Procurement Officer | $3.0M 23,618 shares | -166% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.